A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A66.6 KBAdamas Pharmaceuticals IncFeb 14, 9:55 PM ET·0001193125-22-042671
- SC 13G/A61.2 KBAdamas Pharmaceuticals IncFeb 11, 7:47 PM ET·0000935836-22-000128
- SC 13G/A87.8 KBAdamas Pharmaceuticals IncJan 26, 11:00 AM ET·0001493152-22-002255
- SC 13G/A7.3 KBAdamas Pharmaceuticals IncDec 10, 8:52 AM ET·0000315066-21-001898
- 8-K401.5 KBAdamas Pharmaceuticals IncNov 24, 9:18 AM ET·0001104659-21-143338
- 10-Q6.2 MBAdamas Pharmaceuticals IncNov 10, 4:02 PM ET·0001328143-21-000075
- SC 13G/A112.6 KBAdamas Pharmaceuticals IncOct 20, 3:42 PM ET·0001493152-21-025871
- SC 13D117.1 KBAdamas Pharmaceuticals IncOct 19, 4:26 PM ET·0001104659-21-127593
- 8-K1.3 MBAdamas Pharmaceuticals IncOct 12, 6:59 AM ET·0001104659-21-124979
- 8-K260.7 KBAdamas Pharmaceuticals IncAug 9, 4:04 PM ET·0001328143-21-000072
Insiders
10Tickers
No tickers on record
Addresses
business
1900 POWELL ST., SUITE 1000
EMERYVILLE, CA, 94608
mailing
1900 POWELL ST., SUITE 1000
EMERYVILLE, CA, 94608
Former Names
- NeuroMolecular Pharmaceuticals Inc2006-07-17